PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
1374393-0	1992	3-Deazaadenosine inhibits thrombin-stimulated platelet-derived growth factor production and endothelial-leukocyte adhesion molecule-1-mediated monocytic cell adhesion in human aortic endothelial cells.	3-deazaadenosine	0-16	coagulation factor II, thrombin	Homo sapiens	26-34	
1374393-4	1992	Here, we provide evidence that treatment of EC with the anti-inflammatory agent 3-deazaadenosine (c3Ado) effectively abolished thrombin-stimulated PDGF production and monocyte adhesion.	3-deazaadenosine	80-96	coagulation factor II, thrombin	Homo sapiens	127-135	
6436246-3	1984	Treatment of human umbilical vein endothelial cells with thrombin results in an instantaneous increase in phospholipid methylation which can be blocked by 3-deazaadenosine, a methyltransferase inhibitor.	3-deazaadenosine	155-171	coagulation factor II, thrombin	Homo sapiens	57-65	
6436246-4	1984	3-Deazaadenosine also blocks the thrombin-induced Ca2+ influx into endothelial cells and the release of von Willebrand factor, indicating that these processes are coupled.	3-deazaadenosine	0-16	coagulation factor II, thrombin	Homo sapiens	33-41